Carnegie Investment Counsel Purchases 88 Shares of Intuitive Surgical, Inc. $ISRG

Carnegie Investment Counsel increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.3% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 750 shares of the medical equipment provider’s stock after purchasing an additional 88 shares during the period. Carnegie Investment Counsel’s holdings in Intuitive Surgical were worth $408,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Norway Savings Bank lifted its holdings in shares of Intuitive Surgical by 53.4% in the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after purchasing an additional 910 shares in the last quarter. IronOak Wealth LLC. bought a new position in shares of Intuitive Surgical in the 2nd quarter worth $1,099,000. Trust Co. of Oklahoma bought a new position in shares of Intuitive Surgical in the 2nd quarter worth $363,000. Neville Rodie & Shaw Inc. lifted its holdings in shares of Intuitive Surgical by 11.9% in the 2nd quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock worth $5,666,000 after purchasing an additional 1,110 shares in the last quarter. Finally, Sax Wealth Advisors LLC lifted its holdings in shares of Intuitive Surgical by 218.1% in the 2nd quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock worth $1,334,000 after purchasing an additional 1,684 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. Sanford C. Bernstein reiterated an “outperform” rating and issued a $685.00 target price on shares of Intuitive Surgical in a report on Tuesday, October 21st. Evercore ISI dropped their price objective on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 7th. The Goldman Sachs Group dropped their price objective on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a research note on Wednesday, October 1st. Daiwa Capital Markets raised their price objective on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research note on Friday. Finally, Piper Sandler raised their price objective on Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $602.32.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $546.51 on Monday. The business’s fifty day moving average is $458.09 and its 200-day moving average is $497.11. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The stock has a market capitalization of $195.91 billion, a price-to-earnings ratio of 72.29, a PEG ratio of 5.02 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same quarter last year, the firm posted $1.84 EPS. The firm’s revenue for the quarter was up 22.9% on a year-over-year basis. Research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In related news, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director owned 739 shares of the company’s stock, valued at approximately $325,669.91. This trade represents a 31.19% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 30,031 shares of company stock valued at $14,177,895. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.